Public to Private - LBO
Is there any advantage in LBOs for going from public to private? Or is there similar opportunity in private buyouts?
Is there any advantage in LBOs for going from public to private? Or is there similar opportunity in private buyouts?
| +86 | Nothing to do at work & bored to hell | 9 | 13m |
| +67 | Do people over-index on 'moats' | 20 | 22h |
| +51 | Predicted Net Worth in Trodden Finance Path by 60? | 20 | 17m |
| +42 | Biggest (avoidable) failures in PE Investments? | 23 | 1d |
| +38 | Why is ROIC never really a topic when looking at companies IRL | 11 | 3d |
| +26 | SGE Final Round (Investment Summer Analyst) - Case Study & Technicals? | 13 | 6d |
| +19 | Senior IR Lifestyle | 3 | 5d |
| +12 | How to approach Buyside Recruiting | 3 | 4d |
| +12 | NY LMM PE Recruiting | 3 | 18h |
| +12 | Honest opinions needed about lateraling | 4 | 1d |
Career Resources
Take-privates present a unique opportunity different from private buyouts. In a theoretical world, the public markets are perfect (everything is valued correctly) and there are inefficiencies in the private markets, but sometimes it goes the other way.
A PE firm will target a public company they consider to be undervalued by the public markets, and believe would far better as a private enterprise. This is initially spotted by a gap between the TEV/EBITDA multiple of the public company and its private company peers (some would argue this can be explained by differences in growth, quality etc. but a PE firm may have a contrarian thesis). The thesis revolves around the various reasons it could be undervalued: * Recent bad news - a scandal, bad PR, executives complications - some companies have legacy events weighing down their stock prices * Pressure of quarterly reporting, which may prevent internal investment, R&D and product development projects - many PE firms believe they can create better companies with better products if they are out of the eye of public markets for an extended period of time e.g. Advent / Forescout (Forescout's quarterly reporting has weighed on its stock price) [Advent pulled out of the deal due to COVID]; Siris / Travelport (the bet here was likely that Travelport could trade at a much higher "sexy" fintech/payments angle in the private markets) * Making a major transition - in recent times, this is often an on-premise to cloud SaaS revenue model transition, which has a high risk of failure so public markets will often punish the company for it. PE firms can shepherd the company through such a transition. E.g. Thoma Bravo / Instructure, when Instructure was shifting to its new Canvas product * "Under-the-radar" low volume stocks - some companies have great fundamentals but don't get enough traction / coverage in the stock markets * Geographic arbitrage - many European tech companies have historically been undervalued relative to their US peers. Again, could be explained by geographic macro factors (Europe is slower growth) but a PE firm may believe otherwise * Opportunity for a strategic merger - a PE firm may combine the public company with a major private competitor it owns e.g. H&F's Ultimate Software + Kronos, Permira's Knot Worldwide + WeddingWire, Veritas' athenahealth + Virence Health
Super helpful, thank you!
Aut est perferendis excepturi asperiores consequatur. Qui atque id molestias eum ut non quia. Distinctio quia aut numquam vel dolorem corrupti odio quas. Quasi consequatur ut reiciendis nihil esse ut reprehenderit.
Velit perferendis iusto est cum qui fugit quasi. Voluptatem rem laboriosam eaque ad voluptas. Excepturi et numquam consequuntur nostrum. At quam et nihil aut dolore dolorem reprehenderit.
Sit ut qui in ullam molestiae animi. Non ut adipisci ipsa vero tempora ducimus. Placeat illum optio qui minima.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...